Latest filing published 11 Feb 2022 for Arch Biopartners Inc., €17k.
This profile gathers the share dealings of Claude Allary in Arch Biopartners Inc. In total, 3 filings cover trades dated from 12 October 2019 to 31 August 2021.
No open-market sale appears; the market trades are 1 purchase worth €15k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 2 option exercises.
The latest filing, published on 11 February 2022, reports an option exercise of €17k in Arch Biopartners Inc. The most recent open-market purchase was published on 4 February 2021, 2,090 days ago. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations